PTGER1 and myeloid sarcoma: Nevertheless, EP1 potentially contributes to the disruption of the BBB, as blocking or genetically deleting EP1 in an ischemic murine model led to reduced BBB permeability, presumably through the downregulation of MMP-9, which in MS is found to be elevated in serum of PwRRMS [46–48].